EXKIVITY 40 mg Oral Capsule
RxNorm 2570748
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2570748 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: EXKIVITY 40 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SYPrescribable
Synonym (SY):
Exkivity 40 mg (as mobocertinib succinate 48.06 mg) Oral Capsule
(Atom ID: 12686532)
PSNPrescribable
Prescribable Name (PSN):
EXKIVITY 40 mg Oral Capsule
(Atom ID: 12686535)
SYPrescribable
Synonym (SY):
Exkivity 40 mg Oral Capsule
(Atom ID: 12686531)
SBDPrescribable
Semantic Branded Drug (SBD):
Mobocertinib 40 mg Oral Capsule [Exkivity]
(Atom ID: 12686530)
Patient Education
Mobocertinib
Mobocertinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that cannot be removed by surgery and has spread to other parts of the body either during or after treatment with platinum chemotherapy medications. Mobocertinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop or slow the spread of cancer cells and may help shrink tumors.
[Learn More]
* Please review the disclaimer below.